Search

everythinglearnresearchcommunity

for

Search:↓

No significant link between male pattern baldness and COVID-19 severity was found.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

COVID-19 can cause skin issues like hives, rashes, and chickenpox-like eruptions, with women aged 31-40 being the most affected.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

COVID-19 can cause different types of hair loss, and proper diagnosis by a specialist may be needed.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

PRP treatment effectively reduces hair loss after COVID-19.

Covid-19 affected asthmatic patients in Western Saudi Arabia.

Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.

Public interest in hair loss increased during the COVID-19 pandemic.

Balding might help identify men at higher risk for severe COVID-19, but more research is needed.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

COVID-19 may cause temporary hair loss due to the body's immune response.

Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

COVID-19 is linked to temporary hair loss, especially in women.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

COVID-19 can cause hair loss due to stress, with inflammation markers like D-dimer levels playing a role.

COVID-19 increased hair loss cases, but vaccination did not.